ConductScience.org, home

Trial · NCT04126304

Mycoplasma Infection Rate and Macrolides Resistance in Children With Acute Respiratory Tract Infection

NCT04126304, Unknown, Shanghai Children's Medical Center

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Mycoplasma Infection Rate and Macrolides Resistance in Children With Acute Respiratory Tract Infection. Trials, record NCT04126304. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04126304

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Mycoplasma Infection Rate and Macrolides Resistance in Children With Acute Respiratory Tract Infection
NCT number
NCT04126304
Status
Unknown
Enrollment
2,312 participants, estimated
Lead sponsor
Shanghai Children's Medical Center
Conditions
Respiratory Tract Infections
Interventions
Azithromycin, non-macrolides antibiotics, Mycoplasma detection, Data collection, Data collection
First posted
2019-10-15
Last updated
2019-10-15

Source ClinicalTrials.gov

Registered outcomes5

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryMP infection ratesOn enrollment 1 dayRespiratory illnesses include MP infection rates in children with outpatient (common cold, acute bronchitis, and chronic cough) and hospitalized (community-acquired pneumonia).
SecondaryMP macrolides drug resistance gene rateOn enrollment 1 dayThe detection rate of MP macrolides drug resistance gene was isolated from respiratory disease cases
SecondarySensitivity and specificity of MP rapid detection methodOn enrollment 1 daySensitivity and specificity of MP rapid detection method (antigen and antibody detection rapid colloidal gold method) for diagnosis of MP infection
SecondaryAn early prediction model of refractory MP pneumoniaCommunity acquired pneumonia 30 days after dischargeAn early prediction model of refractory MP pneumonia caused by MRMP was established
SecondaryClinical efficacy of azithromycinCommon cold and acute bronchitis for 7 days ;Post-infection cough for 14 daysCommon cold and acute bronchitis on enrollment, day 3 and day 7;Post-infection cough on the day after outpatient visit, day 3, day 7, and day 14

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers18

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
15293621RESULTPubMed
15561835RESULTPubMed
21526943RESULTPubMed
22209916RESULTPubMed
22701675RESULTPubMed
23279613RESULTPubMed
23369797RESULTPubMed
23716043RESULTPubMed
24626238RESULTPubMed
26613689RESULTPubMed

1 to 10 of 18

See all 18 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT04126304

GET https://conductscience.org/api/trials/v1/NCT04126304/registered